3Xu J,Cui G,Esmailian F,ct al. Atrial extracclular matrix remodeling and the maintenance of atrial fibrillation[J]. Circulation, 2004,109 : 363.
4Nattel S,Shiroshita-Takeshita A,Cardin S,et al. Mechanisms of atrial remodeling and clinical relevance[J]. Curr Opin Cardiol, 2005,20(1):21.
5Li D,Shinagawa K,Pang L,et al. Effects of angiotensin- converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J]. Circulation,2001,104(21) :2608.
6Kojodjojo P, Kanagaratnam P, Markides V,et al. Age-related changes in human left and right atrial conduction [J]. J Cardiovasc Electrophysiol,2006,17(2) :120.
8Boesen CC,Radaev S,Motyka SA,et al. The 1.1 A crystal structure of human TGF- beta type Ⅱ receptor ligand binding domain[J]. Structure,2002,10(7):913.
10Verheule S, Wilson E, Everett T. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation.Circulation, 2003,107:2615-2622.
5Nattel S. New ideas about atrial fibrillation 50 years on [J]. Nature,2002,415(3) :219.
6Xu J, Cui G, Esmailian F, et al. Atrial extracelular matrix remodeling and the maintenance of atrial fibrillation[J].Circulation, 2004,109(3) : 363.
7Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy,valvular disease and arrhythmia[J]. Immunology, 2006,118(1) : 10.
8Nattel S, Shiroshita-Takeshita A, Cardin S, et al. Mechanisms of atrial remodeling and clinical relevance[J]. Curr Opin Cardiol,2005,20(1) :21.
9Lim H,Zhu YZ. Role of transforming growth factor-beta in the progression of heart failure[J]. Cell Mol Life Sci, 2006,63(22) :2584.
